{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:07:52Z","timestamp":1780477672082,"version":"3.54.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2017,8,2]]},"DOI":"10.18632\/aging.101271","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T16:10:29Z","timestamp":1501690229000},"page":"1885-1897","source":"Crossref","is-referenced-by-count":20,"title":["Epigenetic silencing of miR-338 facilitates glioblastoma progression by de-repressing the pyruvate kinase M2-\u03b2-catenin axis"],"prefix":"10.18632","volume":"9","author":[{"given":"Bo","family":"Han","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingchao","family":"Chen","sequence":"additional","affiliation":[{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"},{"name":"Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"},{"name":"Beijing Neurosurgical Institute, Beijing, 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnosis, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Ming","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Neuroscience Institute, Heilongjiang Academy of Medical Sciences, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanlu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China"},{"name":"Neuroscience Institute, Heilongjiang Academy of Medical Sciences, Harbin 150086, China"},{"name":"Chinese Glioma Cooperative Group (CGCG), Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.canlet.2016.01.024","article-title":"CGCG clinical practice guidelines for the management of adult diffuse gliomas.","volume":"37","author":"Li","year":"2016","journal-title":"Cancer Lett"},{"key":"2","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription.","volume":"2","author":"Bird","year":"2011","journal-title":"Genes Dev"},{"key":"3","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1126\/science.1064023","article-title":"Argonaute2, a link between genetic and biochemical analyses of RNAi.","volume":"29","author":"Hannon","year":"2001","journal-title":"Science"},{"key":"4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions.","volume":"13","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ceb.2004.04.003","article-title":"miRNAs on the move: miRNA biogenesis and the RNAi machinery.","volume":"1","author":"Hannon","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","article-title":"The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.","volume":"45","author":"Cantley","year":"2008","journal-title":"Nature"},{"key":"7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4161\/jkst.20662","article-title":"PKM2, STAT3 and HIF-1\u03b1: the Warburg\u2019s vicious circle.","volume":"1","author":"Poli","year":"2012","journal-title":"JAK-STAT"},{"key":"8","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1038\/ncomms5436","article-title":"PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis.","volume":"5","author":"Tang","year":"2014","journal-title":"Nat Commun"},{"key":"9","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1016\/j.yexcr.2009.06.024","article-title":"Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.","volume":"31","author":"Zwerschke","year":"2009","journal-title":"Exp Cell Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1038\/ncomms6566","article-title":"PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells.","volume":"5","author":"Lu","year":"2014","journal-title":"Nat Commun"},{"key":"11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates \u03b2-catenin transactivation upon EGFR activation.","volume":"48","author":"Lu","year":"2011","journal-title":"Nature"},{"key":"12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.","volume":"15","author":"Lu","year":"2012","journal-title":"Cell"},{"key":"13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","article-title":"Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.","volume":"4","author":"Mazurek","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5732\/cjc.011.10446","article-title":"Nonmetabolic functions of pyruvate kinase isoform M2 in controlling cell cycle progression and tumorigenesis.","volume":"3","author":"Lu","year":"2012","journal-title":"Chin J Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","article-title":"Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.","volume":"2","author":"Hung","year":"2013","journal-title":"Cancer Cell"},{"key":"16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","article-title":"ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.","volume":"1","author":"Lu","year":"2012","journal-title":"Nat Cell Biol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/neuonc\/noq080","article-title":"Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells.","volume":"1","author":"Purow","year":"2010","journal-title":"Neuro-oncol"},{"key":"18","first-page":"81","article-title":"Significance of the glycolytic pathway and glycolysis related-genes in tumorigenesis of human colorectal cancers.","volume":"1","author":"Lin","year":"2008","journal-title":"Oncol Rep"},{"key":"19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2443.2008.01165.x","article-title":"Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein.","volume":"1","author":"Ishii","year":"2008","journal-title":"Genes Cells"},{"key":"20","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1073\/pnas.1014769108","article-title":"Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.","volume":"10","author":"Goto","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1111\/j.1349-7006.2010.01562.x","article-title":"Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice.","volume":"10","author":"Wei","year":"2010","journal-title":"Cancer Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1182\/blood-2013-03-489468","article-title":"PPAR\u03b1 and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia.","volume":"12","author":"Spaner","year":"2013","journal-title":"Blood"},{"key":"23","doi-asserted-by":"publisher","first-page":"12694","DOI":"10.18632\/oncotarget.3031","article-title":"Ferroxitosis: a cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanoma.","volume":"5","author":"Naidu","year":"2014","journal-title":"Oncotarget"},{"key":"24","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00109-010-0643-0","article-title":"MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis.","volume":"8","author":"Purrello","year":"2010","journal-title":"J Mol Med (Berl)"},{"key":"25","first-page":"1943","article-title":"MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1\u03b1 in nasopharyngeal carcinoma.","volume":"3","author":"You","year":"2015","journal-title":"Oncol Rep"},{"key":"26","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.3748\/wjg.v19.i14.2197","article-title":"miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened.","volume":"1","author":"Li","year":"2013","journal-title":"World J Gastroenterol"},{"key":"27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11010-014-2211-3","article-title":"MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.","volume":"39","author":"Gu","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"28","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3892\/mmr.2014.2880","article-title":"microRNA-338-3p functions as a tumor suppressor in human non\u2011small\u2011cell lung carcinoma and targets Ras-related protein 14.","volume":"1","author":"Xiao","year":"2015","journal-title":"Mol Med Rep"},{"key":"29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ng.298","article-title":"The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.","volume":"4","author":"Feinberg","year":"2009","journal-title":"Nat Genet"},{"key":"30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1023\/A:1006369223282","article-title":"Wnt signalling in mammalian development and cancer.","volume":"1","author":"Dale","year":"1999","journal-title":"Cancer Metastasis Rev"},{"key":"31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/bbrc.1999.1860","article-title":"Regulation of beta-catenin signaling in the Wnt pathway.","volume":"26","author":"Kikuchi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"32","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.18632\/oncotarget.7650","article-title":"Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas.","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"33","doi-asserted-by":"publisher","first-page":"11681","DOI":"10.18632\/oncotarget.2585","article-title":"Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis.","volume":"5","author":"Jiang","year":"2014","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/neuonc\/nou217","article-title":"Targeting the SMO oncogene by miR-326 inhibits glioma biological behaviors and stemness.","volume":"1","author":"Jiang","year":"2015","journal-title":"Neuro-oncol"},{"key":"35","doi-asserted-by":"publisher","first-page":"18105","DOI":"10.18632\/oncotarget.3906","article-title":"Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.","volume":"6","author":"Jiang","year":"2015","journal-title":"Oncotarget"},{"key":"36","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.18632\/oncotarget.1838","article-title":"ATRX mRNA expression combined with IDH1\/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.","volume":"5","author":"Jiang","year":"2014","journal-title":"Oncotarget"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov217.27","article-title":"PD-L1 expression and prognostic impact in glioblastoma.","volume":"1","author":"Calin","year":"2015","journal-title":"Neuro-oncol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:44:26Z","timestamp":1599065066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.101271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8,31]]}},"alternative-id":["101271","28858851"],"URL":"https:\/\/doi.org\/10.18632\/aging.101271","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]}}}